TRAX First Tracks Biotherapeutics
Company Analysis
Latest News
🔴 First Tracks Biotherapeutics is trading 5% down in pre-market amid broader-market weakness
First Tracks Biotherapeutics is trading at $34.50 (-5.32%) amid a weak broader-market backdrop. - No clear company-specific announcement for September 14,...
🔴 First Tracks Biotherapeutics is trading 5.95% down today — no clear company-specific announcement identified
First Tracks Biotherapeutics is trading 5.95% down now at $35.72; no clear company-specific announcement explaining the September 11, 2026 decline was...
🔴 First Tracks Biotherapeutics is trading 5% down today after hotter-than-expected PPI data
First Tracks Biotherapeutics is trading 5.21% down now at $37.51 as September 10, 2026 markets sell off following hotter-than-expected Producer Price Index...
🔴 First Tracks Biotherapeutics is trading 5% down today as Brent crude nears $100 amid regional conflict
First Tracks Biotherapeutics is trading 5.12% down now at $39.66, moving lower alongside a weak September 9, 2026 market amid elevated oil prices and Middle...
🟢 First Tracks Biotherapeutics is trading 6.38% up today — no confirmed company-specific catalyst found
First Tracks Biotherapeutics is trading $43.04, up 6.38% now, with no confirmed company-specific catalyst identified. - A Wells Fargo healthcare conference...
First Tracks Biotherapeutics downgraded to Sell, after director sheds 71% stake
Wall Street Zen downgraded First Tracks Biotherapeutics (NASDAQ:TRAX) from Hold to Sell on September 5, 2026. The rating change followed a 4.8% drop in share...
🔴 First Tracks Biotherapeutics is trading 5.8% down today — no confirmed company-specific explanation
First Tracks Biotherapeutics is trading at $42.64 (-5.83%), with no confirmed September 3, 2026 company-specific announcement explaining the decline. - Recent...
🟢 First Tracks Biotherapeutics is trading 12.22% up today
First Tracks Biotherapeutics is trading 12.22% up at $46.20, based on the provided live price context, with no confirmed catalyst identified. - No clear...
🔴 First Tracks Biotherapeutics is trading 6.58% down today amid biotech selloff over hawkish Fed signals
First Tracks Biotherapeutics is trading 6.58% down now at $41.80, primarily amid a biotech-sector selloff linked to concerns that Federal Reserve Chair Kevin...